Knowles, Joshua Wiley
- Stanford University · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #8,964
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$1.1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#8,964
By linked amount among FY2023 PIs
Earliest Year Loaded
2019
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Knowles, Joshua Wiley as a PI. Multi-PI records show the full award amount for context.
- 5R01DK120565-05R01Contact PICharacterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studiesStanford University · Internal Medicine (NIH department code)$620.3Kaward amount
- 5R01DK116750-05R01Contact PIMechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial DysfunctionStanford University · Internal Medicine (NIH department code)$484.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Knowles, Joshua Wiley as a PI.
FY2023 award administered by Stanford University (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardStanford University
- 2019$500K Cumulative Funding
- 2019$1M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #7964
- 2020R01 Grant Holder
- 2021$2M Cumulative Funding